本页面由Tiger Trade Technology Pte. Ltd.提供服务

梯瓦制药

31.26
-0.3500-1.11%
盘后31.270.0100+0.03%17:54 EDT
成交量:468.22万
成交额:1.47亿
市值:364.18亿
市盈率:25.83
高:31.75
开:31.72
低:31.21
收:31.61
52周最高:37.35
52周最低:13.04
股本:11.65亿
流通股本:11.42亿
量比:1.27
换手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):1.21
每股收益(LYR):1.21
净资产收益率:20.79%
总资产收益率:6.17%
市净率:4.60
市盈率(LYR):25.83

数据加载中...

2025/05/20

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/05/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

重要事件披露

Form 8-K - Current report
2025/04/15

SEC问询函

Form CORRESP - Correspondence
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/29

重要事件披露

Form 8-K - Current report
2024/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities